PRQR

#6352
ProQR Therapeutics N.V. Ordinary Shares
1.59
+3.25%
Sector:
Base:
Profit Currency:
Daily Range
1.59
1.59
Year Range
1.07
3.10
Daily Change
+3.25%
Monthly Change
-4.79%
6 month change
-28.05%
Year Change
-32.91%
Previous Close
1.54
Open
1.59
Bid
Ask
Low
1.59
High
1.59
Volume
6
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value 20202021202220232024 TTM

ProQR Therapeutics N.V

ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands, with a presence in Cambridge, Massachusetts, US. The company was funded in 2012 by chief executive officer Daniel A. de Boer. It specializes in the development of RNA therapeutics using its RNA editing platform technology called Axiomer.

News